Collectively, these results suggest that high expression of HSPA2 and DNAJC20 is associated with low-risk breast cancer, whereas high expression of HSP90AA1, CCT1, CCT2 and CCT6A correlates with high-risk breast cancer. Here, TCP1 is linked to breast carcinoma.